Carl Zeiss licences digital pathology from Olympus

Share this on social media:

Carl Zeiss Microscopy and Olympus America have signed a non-exclusive worldwide licensing agreement allowing Carl Zeiss to access an extensive portfolio of patents held by Olympus in the field of digital pathology and virtual microscopy. The patents included in the licensing deal cover methods and equipment for creating, storing and delivering virtual microscopy slides. The technology enables individuals to view and share high-resolution virtual microscopy images over the Internet.

‘The handling of digital data has become a major driver of the development of modern microscopy,’ said Dr Bernhard Ohnesorge, member of the board and general manager BioSciences Division of Carl Zeiss Microscopy. ‘Integrating the virtual slide functionality into our research microscope systems will enable our customers to become more efficient and to explore new scientific approaches. This will help them to better understand the root causes of the most challenging diseases.’

‘Global adoption of digital slide scanning continues to expand into new medical and scientific applications,’ said Brad Burklow, executive director business development, Scientific Equipment Group, Olympus Corporation of the Americas. ‘Olympus is the holder of many important patents in this area, and we feel it is vital to allow broad access to these technologies in order to advance the field of pathology and medical research. We are confident that leveraging these technologies will enhance healthcare for patients around the world.’

Recent News

04 January 2021

The acquisition adds Flir's thermal and infrared imaging technologies to Teledyne's visible imaging capabilities

21 December 2020

Perceptron's 3D measuring solutions complement Isra Vision's 3D vision systems and, together, they offer products for automating key applications along the automotive production line

16 December 2020

Recycleye’s vision system is capable of detecting and classifying items in waste streams, broken down by material, object and brand

16 December 2020

The company increased its forecast from €165m to a sales corridor of €169m to €171m for the current financial year